Site Visit Presentation

RNS Number : 7318I
RHI Magnesita N.V.
28 November 2018
 

 

 

RHI Magnesita N.V.

("RHI Magnesita" or the "Company")

 

 

Site Visit Presentation

 

RHI Magnesita N.V. (LSE: RHIM) is holding a site visit today for analysts and investors to its Leoben R&D Centre and Veitsch Plant in Austria. The presentation will be made available on the Company's website at: https://ir.rhimagnesita.com/investors/results-presentations/.

 

 

For further enquiries, please contact:

 

Guy Marks, Head of Investor Relations

Tel +44 7741 730681

E‐mail: guy.marks@rhimagnesita.com

 

Stefan Rathausky, Head of Corporate Communications

Tel +43 50213‐6059

E‐mail: stefan.rathausky@rhimagnesita.com

 

 

 

About RHI Magnesita

 

RHI Magnesita is the global leading supplier of high-grade refractory products, systems and services which are indispensable for industrial high-temperature processes exceeding 1,200°C in a wide range of industries, including steel, cement, non-ferrous metals, and glass, among others. With a vertically integrated value chain, from raw materials to refractory products and full performance-based solutions, RHI Magnesita serves more than 10,000 customers in nearly all countries around the world.

 

The Company has unmatched geographic diversification with more than 14,000 employees in 35 main production sites and more than 70 sales offices. RHI Magnesita intends to use its global leadership position in terms of revenue, greater scale, complementary product portfolio and diversified geographic presence around the world to target opportunistically those countries and regions benefitting from more dynamic economic growth prospects.

 

Its shares have a premium listing on the London Stock Exchange (symbol: RHIM) and are a constituent of the FTSE 250 index.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUWVNRWAAAURA
UK 100

Latest directors dealings